With Atrial Fibrillation (AFib), Change Can Come in 
a Matter of Moments

In 2020, about 8.4 million people in the United States are projected to have 
AFib, and that number is expected to 
grow to an estimated 12 million people 
by 2030
.1 Given the expected growing 
number of people with AFib, this could 
mean there may be more people at a 
higher risk of stroke as a result.2

Moments That Matter

People with AFib share their stories and explain the importance of working with a doctor to help manage the condition.

Orange Electrocardiogram Heart And AFib Patients Icons

Why Is AFib Awareness Important?

If you or a loved one have undiagnosed AFib, life may change in a matter of moments. With AFib cases increasing, now can be a good time to learn about AFib’s connection to stroke and understand the importance of  
diagnosis.

In the case that you have already been diagnosed with AFib, it's important to work with your doctor to help manage the condition and talk about a plan that may be right for you. While an AFib diagnosis can impact people differently, collaborating with a doctor allows you to be proactively involved in the management of your health.

What Is the Connection Between AFib and Stroke?

Take a look inside the heart to see how AFib can cause blood to pool in the upper chambers of the heart, potentially forming a clot, and may possibly lead to 
a life-threatening or debilitating stroke.3

In case you missed it...

The Alliance—Bristol Myers Squibb and Pfizer

The Bristol Myers Squibb–Pfizer Alliance established an awareness initiative in late 2018, called Matter of Moments: Recognizing AFib-Stroke Risk. Why “Matter of Moments?” Because in a matter of moments, the lives of individuals, as well as their family and friends, can be affected by AFib-related stroke. On the other hand, AFib may also be detected in a matter of moments as a part of routine medical care.

The Alliance created the Matter of Moments initiative to help raise awareness of AFib, its connection to stroke, and the importance of a timely AFib diagnosis. We are doing this by collaborating with expert health-care professionals and advocacy organizations so that patients and health-care providers can be better prepared for a future where AFib may be more prevalent.

This global alliance combines Bristol Myers Squibb's long-standing strengths in cardiovascular disease with Pfizer's global scale and expertise in this field.

Learn More About AFib

Up Beat Logo American College Of Cardiology Logo Preventive Cardiovascular Nurses Association Logo National Blood Clot Alliance Logo Alliance For Aging Research Logo

The American Heart Association (AHA) is a national voluntary health agency dedicated to fighting heart disease and stroke. Learn more about AFib from the AHA.

Bristol Myers Squibb and Pfizer do not endorse these organizations. The information included on this site and the links provided by Bristol Myers Squibb and Pfizer are meant for informational purposes only and are not meant to replace a physician’s medical advice.

References:

  1. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population. Am J Cardiol. 2013;112(8):1142–1147.
  2. Centers for Disease Control and Prevention (CDC). Atrial Fibrillation.
     https://www.cdc.gov/heartdisease/atrial_fibrillation.htm. Accessed August 6, 2020.
  3. National Heart, Lung, and Blood Institute (NHLBI). Atrial fibrillation.
     https://www.nhlbi.nih.gov/health-topics/atrial-fibrillation. Accessed March 1, 2019.